Some experts say we’re in “the golden age of biotechnology.” Scientific advances are opening up possibilities for the treatment and prevention of diseases that...
Amid rising interest rates and a drastic rotation out of technology, fintech stocks have taken a beating this year, vastly underperforming the overall market....
Given the unprecedented situation with major threats Russia and China, Washington is not the only world power taking steps to strengthen the technical capabilities...
Stocks declined last week, posting a second straight weekly loss following a hawkish Fed meeting and mixed inflation data. The Federal Reserve lifted...